Carlos,
To some degree it is true that the manufacturers of these products need to fund studies to promote the safety and efficacy of their drugs. And these manufacturers should bear these costs to substantiate their claims. As I said take out of this what you will, but also note that this article does neither verify or state the efficacy as a drug that will help detect tumors that are either indolent or aggressive prostate cancer. I am critical of all studies in prostate cancer as for one thing I have seen many design their "studies" in particular for increasing the sales of products or services. This is a great example. If you have an enlarged prostate, Avodart is approved for that treatment. So is Flowmax, Proscar, and a few others.
Then there's another side of this. It's almost like GSK is suggesting that men should start taking Avodart just for this purpose ~ and that's absolutely absurd. You should take it if you have an enlarged prostate and your doctor approved it.
Ironically, there is a study out there that suggests that finasteride (Proscar) helps men at high risk for prostate cancer delay the onset of prostate cancer. But that same study also showed that the non-placebo arm of the study had a higher incidence of more aggressive tumors. So now the question isn't does it prevent the onset, but rather just suppress the ability to detect prostate cancer? The spin on this article seems to say the same thing in a different way.
Tony
Post Edited (TC-LasVegas) : 12/17/2010 4:41:59 PM (GMT-7)